Investigate retinal cholesterol homeostatis in an Alzheimer's disease mouse model

Project Details


Alzheimers Disease (AD) is the most common cause of dementia and is a growing global health concern, affecting 850,000 in the UK. AD is characterised by a spectrum of cognitive and neuropsychiatric symptoms, including severe memory loss, behavioural changes, disorientation, visual impairments,sleep disturbances, and at late stages: difficulties in walking and swallowing and invariably death. Abnormal accumulation of amyloid beta in the retina of AD patients may contribute to visual function defects and this and the underlying biological causes shall be the focus of this study.
Short titleRetinal cholesterol homeostatis in an Alzheimer's disease
Effective start/end date1/12/2028/02/22


  • Tenovus Scotland: £19,984.00

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.